PWMAI
PTGX icon

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Protagonist Therapeutics PTGX Stock Holding History

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20
Closed -$2.11K – 571
2026
Q1 		$2.11K Buy
+20
New +$1.77K ﹤0.01% 464

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s PTGX Position: Q2 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of Protagonist Therapeutics (PTGX) in Q2 2026, closing a stake of 20 shares — an estimated $2.11K sold.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in PTGX in Q1 2026 and held it in 1 quarter. The position peaked at $2.11K in Q1 2026. 134 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining Protagonist Therapeutics position as of Q2 2026 after selling out during the quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 20 Protagonist Therapeutics shares in Q2 2026, an estimated $2.11K.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in Protagonist Therapeutics in Q1 2026 and held it in 1 quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s Protagonist Therapeutics position peaked at $2.11K in Q1 2026.
  • 134 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2026, filed 7 Aug 2026.